RoB 2.0: A revised tool to assess risk of bias in randomized trials pt1
The revised tool for assessing risk of bias in randomized trials (RoB 2.0) builds on the established Cochrane risk-of-bias tool first released through the Cochrane Handbook for Systematic Reviews of Interventions in 2008 and updated in 2011. The development team have reacted to feedback and evaluations of the original tool and made several amendments and improvements.
This webinar, which is part of the Cochrane Learning Live series, is presented by Dr Matthew Page, who demonstrates the improvements and changes in RoB 2.0.
Видео RoB 2.0: A revised tool to assess risk of bias in randomized trials pt1 канала Cochrane Training
This webinar, which is part of the Cochrane Learning Live series, is presented by Dr Matthew Page, who demonstrates the improvements and changes in RoB 2.0.
Видео RoB 2.0: A revised tool to assess risk of bias in randomized trials pt1 канала Cochrane Training
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![What's new... Part 2: Handbook Chapter 4 - guidance on selecting studies](https://i.ytimg.com/vi/sV4sGNWIIBQ/default.jpg)
![Part 2: Sucra – yes or no?](https://i.ytimg.com/vi/zj2XCzxhaIk/default.jpg)
![Part 2: Search, study selection, data extraction, risk of bias assessment, analysis](https://i.ytimg.com/vi/wlBwD5F85Bs/default.jpg)
![Part 1: The problem of missing data](https://i.ytimg.com/vi/OiqvpqxMWcI/default.jpg)
![Part 1: Presentation](https://i.ytimg.com/vi/GJQEOFsile0/default.jpg)
![How mental health experts & patients contribute to a first aid manual for mental health problems](https://i.ytimg.com/vi/KdmaLiFVCts/default.jpg)
![Part 2: Questions & answers](https://i.ytimg.com/vi/5N8RVNS62hs/default.jpg)
![Part 1: Introduction](https://i.ytimg.com/vi/PklZfECCQp4/default.jpg)
![Part 1: "Crossnma" package and the theory behind it](https://i.ytimg.com/vi/oTEmaQYeioQ/default.jpg)
![Questions & Answers](https://i.ytimg.com/vi/30g6SorDI18/default.jpg)
![Artificial intelligence (AI) technologies in Cochrane - Part 2 #cochranelearninglive #AI](https://i.ytimg.com/vi/8GeygNImb2s/default.jpg)
![Shared Decision-Making: Experiences from Karen Morley](https://i.ytimg.com/vi/vJzC7FPDhqc/default.jpg)
![Communicating synthesised complex public health evidence to decision makers and end users](https://i.ytimg.com/vi/bEj_sJiOryo/default.jpg)
![Visualising systematic review search strategies to assist information specialists](https://i.ytimg.com/vi/GuTF12b1wEs/default.jpg)
![Does level of experience matter when abstracting data for systematic reviews?](https://i.ytimg.com/vi/dYTtHhiL_S4/default.jpg)
!['What has kept you involved in Cochrane's work for so many years?' - answer by Alison Weightman](https://i.ytimg.com/vi/ivjoB4T8by0/default.jpg)
![Meta-analysis of time-to-event data (Cochrane Statistical Editor training 2022)](https://i.ytimg.com/vi/WnXjMRgV95Y/default.jpg)
![Agreement in the assessment of SRs with the AMSTAR 2 tool: novice vs. expert methodologists](https://i.ytimg.com/vi/fziMXhUONiY/default.jpg)
![Part 2: Prospective meta-analysis (PMA)](https://i.ytimg.com/vi/l5BtCytNkrU/default.jpg)
![Part 1: Selecting studies](https://i.ytimg.com/vi/2NYwrfRMBKI/default.jpg)
![How to approach writing a Background section](https://i.ytimg.com/vi/q7I_5srkds0/default.jpg)